AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

AZITHROMYCIN in Zimbabwe

9 products registered with MCAZ 9 active

Brand / ProductReg. No.HolderStatusExpires
AZIMAZ
POWDER, FOR SUSPENSION; ORAL
2026/7.2.5/7460ARAVAS PHARMACEUTICALSactive7 Jun 2031
AZIMAZ
TABLET, COATED; ORAL
2026/7.2.5/7459ARAVAS PHARMACEUTICALSactive7 Jun 2031
AZITHROMASH
TABLET, COATED; ORAL
2025/7.2.5/7105PHARMASOLUTIONS (PVT) LTDactive19 Oct 2030
SKY PHARM - AZITHROMYCIN
TABLET, COATED; ORAL
2014/7.2.5/4901SKY PHARMACEUTICALS LTDactive28 Jul 2029
CP-AZITHROMYCIN 500
TABLET, COATED; ORAL
2019/7.2.5/5850COSPHARM INVESTMENTS (PTY) LTDactive31 Dec 2027
ZITHROMAX IV
INJECTABLE; IV (INFUSION)
2010/7.2.5/4647PFIZER SPECIALITIES LTDactive31 Dec 2027
ZITHROMAX
TABLET, COATED; ORAL
2001/7.2.5/3954PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/Lactive31 Dec 2027
ZMAX
POWDER, FOR SUSPENSION; ORAL
2010/7.2.5/4603PFIZER SPECIALITIES LTDactive31 Dec 2027
ZITHROMAX
POWDER, FOR SUSPENSION; ORAL
92/7.2.5/2684PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/Lactive31 Dec 2027

AZITHROMYCINMCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing AZITHROMYCIN, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track AZITHROMYCIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.